A Phase 1, Dose-Escalation/Dose-Expansion Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamic Effects of Orally Administered CB-5083 in Subjects with Lymphoid Hematological Malignancies
Research Grant
Administered By
Ophthalmology
Awarded By
Cleave Biosciences
Start Date
June 27, 2016
End Date
May 9, 2018
Administered By
Ophthalmology
Awarded By
Cleave Biosciences
Start Date
June 27, 2016
End Date
May 9, 2018